These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. 5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases. Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Ado M; Tsuyoshi T; Dos Santos O; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Weiss WJ; Shlaes DM; Mansour TS Bioorg Med Chem; 2008 Feb; 16(4):1890-902. PubMed ID: 18061461 [TBL] [Abstract][Full Text] [Related]
11. The oxazolidinone antibacterial agent DuP 105 does not act on cell wall biosynthesis or on a beta-lactamase. Silverman RB; Tran N; Sinha RK; Neuhaus FC Biochem Biophys Res Commun; 1993 Sep; 195(2):1077-80. PubMed ID: 8373386 [TBL] [Abstract][Full Text] [Related]
12. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter. Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432 [No Abstract] [Full Text] [Related]
13. [Re-evaluation of the gastrointestinal effects of beta-lactam inhibitors of beta-lactamase]. Sábada B Rev Esp Quimioter; 1998 Dec; 11(4):377-9. PubMed ID: 10336322 [No Abstract] [Full Text] [Related]
14. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update. Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910 [TBL] [Abstract][Full Text] [Related]
15. Assays for beta-lactamase activity and inhibition. Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319 [TBL] [Abstract][Full Text] [Related]
16. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity. Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896 [TBL] [Abstract][Full Text] [Related]
17. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery. Sharma A; Khuller GK; Sharma S Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of some beta-lactams in combination with dicloxacillin against Mycobacterium fortuitum. Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Oratore A; Orefici G J Chemother; 1989 Jul; 1(4 Suppl):339-41. PubMed ID: 16312429 [No Abstract] [Full Text] [Related]
19. New antibacterial agents: patent applications published in 2010. Stokes SS; Morningstar M; Kocis H; Verheijen JC Pharm Pat Anal; 2012 Nov; 1(5):601-20. PubMed ID: 24236928 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]